Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -542 | -367 | -279 | -161 | -675 |
| Depreciation Amortization | 227 | 187 | 149 | 83 | 335 |
| Other Working Capital | 2 | 10 | -3 | -4 | 13 |
| Other Operating Activity | 73 | 0 | 0 | 0 | 67 |
| Operating Cash Flow | $-240 | $-170 | $-133 | $-82 | $-260 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | -2 | 0 | N/A |
| Other Investing Activity | 0 | -2 | 0 | -2 | 0 |
| Investing Cash Flow | $-2 | $-2 | $-2 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 222 | 122 | 67 | 32 | 269 |
| Common Stock Issued | 1 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $223 | $122 | $67 | $32 | $269 |
| Beginning Cash Position | 101 | 101 | 101 | 101 | 92 |
| End Cash Position | 81 | 50 | 33 | 49 | 101 |
| Net Cash Flow | $-19 | $-50 | $-67 | $-52 | $9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -240 | -170 | -133 | -82 | -260 |
| Capital Expenditure | -2 | 0 | -2 | 0 | N/A |
| Free Cash Flow | -242 | -170 | -134 | -82 | -260 |